InvestorsHub Logo
Followers 31
Posts 6513
Boards Moderated 0
Alias Born 01/20/2016

Re: None

Wednesday, 07/13/2016 9:01:49 AM

Wednesday, July 13, 2016 9:01:49 AM

Post# of 465898
Can anyone explain why this whole process has taken this long?? Just came upon this PR from Anavex dated Jan.'08 ---At this stage after 8+ years ??? In 2008, once pre-clinical studies have been completed, ANAVEX plans to submitINDapplications for three compounds so that we can commence Phase 1 clinical trials. We expect to submit IND filings for ANAVEX 1-41 (Alzheimer’s) in April 2008, followed by an application for ANAVEX 2-73 (epilepsy) in August 2008, and ANAVEX 7-1037 (colorectal cancer and other solid tumors) by December 2008. ANAVEX 1-41 is expected to be the first compound to reach Phase 1 clinical trials, with human testing expected to commence in late 2008 or early 2009.

Also in 2008, ANAVEX plans to strategically explore marketplace choices and opportunities in theUnited States. The company believes that the benefits of listing on a senior stock exchange would include expanded relationships with the American investment community and the support of a larger, more liquid trading market.

ANAVEX is aiming to sign licensing agreements for its lead CNS candidates following Phase 1 clinical trials. The company is motivated to pursue licensing agreements for its oncology drug candidates at an earlier stage.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News